Patents by Inventor Aldo Pinchera

Aldo Pinchera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9468619
    Abstract: The invention regards the use of triiodothyronine sulfate, commonly named T3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), as such or in association with thyroxine (T4), and pharmaceutical formulations for oral administration thereof.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: October 18, 2016
    Assignee: Bracco S.P.A.
    Inventors: Aldo Pinchera, Livio Cavalieri, Federico Maisano, Giovanni Rivolta, Ferruccio Santini, Fulvia Vella
  • Patent number: 9439883
    Abstract: The invention regards the use of triiodothyronine sulfate, commonly named T3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), as such or in association with thyroxine (T4), and pharmaceutical formulations for oral administration thereof.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: September 13, 2016
    Assignee: Bracco S.P.A.
    Inventors: Aldo Pinchera, Livio Cavalieri, Federico Maisano, Giovanni Rivolta, Ferruccio Santini, Fulvia Vella
  • Patent number: 9012438
    Abstract: The invention regards the use of triiodothyronine sulfate, commonly named T3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), as such or in association with thyroxine (T4), and pharmaceutical formulations thereof.
    Type: Grant
    Filed: November 11, 2003
    Date of Patent: April 21, 2015
    Inventors: Aldo Pinchera, Ferruccio Santini
  • Publication number: 20130281536
    Abstract: The invention regards the use of triiodothyronine sulfate, commonly named T3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), as such or in association with thyroxine (T4), and pharmaceutical formulations for oral administration thereof.
    Type: Application
    Filed: June 13, 2013
    Publication date: October 24, 2013
    Inventors: Aldo PINCHERA, Livio CAVALIERI, Federico MAISANO, Giovanni RIVOLTA, Ferruccio SANTINI, Fulvia VELLA
  • Publication number: 20110245342
    Abstract: The invention regards the use of triiodothyronine sulfate, commonly named T3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), as such or in association with thyroxine (T4), and pharmaceutical formulations for oral administration thereof.
    Type: Application
    Filed: April 8, 2011
    Publication date: October 6, 2011
    Applicant: Bracco S.p.A.
    Inventors: Aldo PINCHERA, Ferruccio Santini, Giovanni Rivolta, Livio Cavalieri, Fulvia Vella, Federico Maisano
  • Publication number: 20050272816
    Abstract: The invention regards the use of triiodothyronine sulfate, commonly named T3S, as a medicament having thyromimetic activity for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), as such or in association with thyroxine (T4), and pharmaceutical formulations thereof.
    Type: Application
    Filed: November 11, 2003
    Publication date: December 8, 2005
    Applicant: Bracco S.p.A.
    Inventors: Aldo Pinchera, Ferruccio Santini